HealthSouth Corporation (NYSE:HLS) CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $43.00, for a total value of $972,875.00. Following the sale, the chief executive officer now owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

HealthSouth Corporation (HLS) traded up 0.11% during mid-day trading on Tuesday, reaching $43.68. The company’s stock had a trading volume of 881,925 shares. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of 15.92 and a beta of 0.61. The stock has a 50-day moving average price of $46.14 and a 200-day moving average price of $44.07.

HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings results on Monday, July 31st. The company reported $0.71 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The firm had revenue of $981.30 million during the quarter, compared to analyst estimates of $976.46 million. During the same quarter in the previous year, the business earned $0.69 EPS. HealthSouth Corporation’s revenue for the quarter was up 6.6% compared to the same quarter last year. Equities research analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Friday, September 29th. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. HealthSouth Corporation’s payout ratio is currently 35.29%.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/08/08/healthsouth-corporation-nysehls-ceo-sells-972875-00-in-stock.html.

Several institutional investors have recently made changes to their positions in HLS. Principal Financial Group Inc. raised its position in shares of HealthSouth Corporation by 10.1% in the second quarter. Principal Financial Group Inc. now owns 1,147,210 shares of the company’s stock valued at $55,524,000 after buying an additional 105,681 shares in the last quarter. Renaissance Group LLC raised its position in shares of HealthSouth Corporation by 1.9% in the second quarter. Renaissance Group LLC now owns 8,288 shares of the company’s stock valued at $401,000 after buying an additional 152 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of HealthSouth Corporation by 161.9% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,075 shares of the company’s stock valued at $391,000 after buying an additional 4,992 shares in the last quarter. Brookstone Capital Management acquired a new position in shares of HealthSouth Corporation during the second quarter valued at $293,000. Finally, Pacer Advisors Inc. raised its position in shares of HealthSouth Corporation by 6.3% in the second quarter. Pacer Advisors Inc. now owns 11,868 shares of the company’s stock valued at $574,000 after buying an additional 703 shares in the last quarter. Hedge funds and other institutional investors own 97.96% of the company’s stock.

A number of research firms recently commented on HLS. Mizuho upped their price objective on HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research report on Monday, July 10th. Zacks Investment Research upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $49.00 price objective for the company in a research report on Wednesday, August 2nd. BidaskClub cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a research report on Thursday, July 13th. Barclays PLC reiterated an “underweight” rating and set a $46.00 price objective (up previously from $44.00) on shares of HealthSouth Corporation in a research report on Monday, May 1st. Finally, ValuEngine cut HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $48.83.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.